Wednesday, February 24, 2010
CALENDAR: A new Green Baron “Trading Alert” will be released before the market open tomorrow, Thursday, February 25. Our “Trading Alerts” are quickly becoming famous for huge moves up on staggering volume within weeks after we initiate coverage. Be sure to check out this brand new stock idea never before mentioned.
Also, a new Green Baron “Stock Alert” has now been scheduled for release on Tuesday, March 2 after the close of trading. This company is involved in the exploration and production of oil and gas. Green Baron members know that stocks in this industry tend to fly after we initiate coverage. Mark this date now!
“Stock Pick” Update
Caleco Pharma
(BB: CAEH)
News Issued After Close Yesterday!
Market Demand for Caleco’s Liver Health Formulation
Company reports on early success of its lead product to inhibit the growth of Hepatitis C virus
The Green Baron Report initiated coverage of Caleco Pharma on October 13, 2009 at .18 per share and subsequently rallied to .35 about a week later up nearly 100% from our profile price. CAEH has been trading primarily between .20 and .30 per share since this rally.
The problem with investing in stocks that are developing a novel new treatment is waiting for test results. Early studies for Caleco’s liver health formula indicate that it has a product that works and its target market is huge. We believe Caleco is going to knock it out of the park, and it is just a matter of time.
In the meantime, it would be wise to accumulate on dips. Therefore, anywhere near .20 per share would make sense based on the chart. Yesterday, CAEH closed at .20. Watch for exciting new development soon from Caleco, and review the news reprinted below:
Feb 23, 2010 4:15:00 PM EST
BELLINGHAM, WASHINGTON -- (MARKET WIRE) - Caleco Pharma Corp. (the "Company" or "Caleco") (OTCBB: CAEH)(FRANKFURT: T3R)(WKN: A0N9Y0) (www.calecopharmacorp.com), a biopharmaceutical and consumer health products company that identifies and develops biotech products, today provides insight into the development strategy for its lead, patent protected product line that targets a segment of the market that includes millions of people suffering from various liver maladies, especially the Hepatitis C Virus (HCV).
"Pre-clinical research and an observational study have indicated that products derived from the company's proprietary "Liver Health" formulation, exhibit anti-viral activity," said John Boschert, Caleco's President and CEO. "We will continue pre-clinical work with these compounds, CPC.12115HP201 and CPC.12115HP202 in 2010 focusing on developing and testing additional derivatives as well as further compound isolation work on the parent herbal formulation. With the anti-viral activity profiles having been demonstrated in two bioassay systems, and considering the observed clinical effects of the parent herbal formulation, the Corporation believes continued preclinical development work is warranted."
The company is pursuing a two-tiered strategy to bring the parent herbal formulation to market while continuing development of CPC.12115HP201 and CPC.12115HP202. The company is actively engaged in pre-commercialization projects related to bringing the proprietary "Liver Health" formulation to worldwide markets as an oral health supplement following additional clinical trials expected to start in the first half of 2010. In addition, derivatives of the parent herbal formulation are being considered for oral supplement development targeted at immune system enhancement and as dermatologic products for use in common chronic dermatologic conditions.
To date, the Company's intellectual property covering the "Liver Health" formulations is comprised of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
About Caleco Pharma Corp.
Caleco Pharma is focused on the ongoing research and development of its pipeline of over-the-counter and prescription medications including its proprietary antiviral and "Liver Health" OTC formulations. In addition Caleco Pharma is developing Dermatological Products based on the active ingredients found in its proprietary formulation. To date, Caleco Pharma's intellectual property covering the Liver Health formulations and derivatives consists of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
Caleco Pharma's shares are traded in the United States on the OTC Bulletin Board (OTCBB: CAEH) and in Germany on the Frankfurt Stock Exchange (WKN: A0N9Y0/ Symbol: T3R.FSE).
This press release may contain, in addition to historic information, forward-looking statements.
These statements may involve known and unknown risks and uncertainties and other factors that may cause the actual results to be materially different from the results implied herein. In particular, there are no assurances that: (i) the United States Patents and Trademarks Office will grant Caleco Pharma a patent in connection with its current patent applications; (ii) Caleco Pharma will be able to manufacture and produce its products or that its products will be effective; or (iii) it will be able to carry out any pre-clinical or clinical trials of its products. (iv) the Company will be able to obtain additional financing in order to meet the costs of the clinical studies of the "Liver Health" formulation and (v) the Company will be able to control the costs of the clinical studies of the "Liver Health" formulation. Readers are cautioned not to place undue reliance on the forward-looking statements made in this press release.
Contacts:
Caleco Pharma Corp.
John Boschert
(360) 306-1133
BlueWater Advisory Group - Investor Relations
Bryan Crane
Managing Director
805-426-5090
“Stock Alert” Update
Worldwide Energy and Manufacturing
(BB: WEMU)
News Issued Monday, February 22
Worldwide Energy and Manufacturing USA Announces Gerald DeCiccio as Chief Financial Officer
On November 30, 2009, The Green Baron Report issued its initiated coverage of Worldwide Energy and Manufacturing as a Green Baron “Stock Alert” at $4.70 per share. WEMU subsequently rallied as high as $7.22 within 45 days, but then dropped backed around our profile price when the Company announced it had raised about $8 million through an equity placement at $4.50 per share.
We believe Worldwide Energy is again at an ideal point for accumulation. The addition capital will be used to expand its solar division. The capital will also shore up its balance sheet so that the Company can file to list on a stronger exchange. If successful, WEMU will become much more attractive to mutual funds and other institutional investors. The Green Baron Report predicts we will see another nice run up in WEMU shares over the next few months. See news reprinted below from Monday:
Feb 22, 2010 5:32:00 PM EST
SOUTH SAN FRANCISCO, CA and SHANGHAI, CHINA -- (MARKET WIRE) -- 02/22/10 --Worldwide Energy and Manufacturing USA, Inc.(OTCBB: WEMU) today announced the appointment of Gerald DeCiccio as Chief Financial Officer, effective February 18, 2010. Jeff Watson, who has resigned as Acting Chief Financial Officer of the company, will continue to serve as Worldwide's President. To focus on his new role, Mr. DeCiccio has resigned as a director of the Company.
Mr. DeCiccio served as a director of Worldwide from June 1, 2009 until his resignation on February 18, 2010. Since June 2007, Mr. DeCiccio has been the Vice President and Corporate Controller of Ritz Interactive, Inc. Prior to that he was the Chief Financial Officer and a board member of GTC Telecom Corp. and its subsidiary, Perfexa Solutions, Inc. (Mr. DeCiccio took GTC public in 1999) and Chief Financial Officer forNational Telephone & Communications, Inc. In these roles, he managed the finance, accounting, SECreporting, treasury, human resources, investor relations, and legal departments. Mr. DeCiccio also held senior financial roles at Newport Corporation and Parker Hannifin Corporation and was a Supervising Senior Accountant for Ernst and Young. He has also been a member of the Board of Directors and Audit Committee for Interplay Entertainment, Inc. and GT Data Corp.
Jimmy Wang, chairman and chief executive officer of Worldwide, commented: "We are very pleased to have Gerald serve as our chief financial officer as his service as a director has been exemplary. His knowledge of our company and his extensive experience in corporate finance and SEC reporting make him a logical choice as we continue to pursue our growth strategies and expand our manufacturing capacity. I'd also like to thank Jeff for his excellent work as Acting CFO and for his continuing work as our President. Both of their talents will be invaluable as we position as a leading solar manufacturer."
About Worldwide Energy and Manufacturing USA, Inc.
Worldwide Energy and Manufacturing USA, Inc. (http://www.wwmusa.com), headquartered in South San Francisco, California, is a profitable 16-year-old engineering-oriented firm specializing in photovoltaic (PV) panel, mechanical, electronics and fiber optic products manufacturing. The company's worldwide customer base includes the industries of solar energy, wireless telecommunications, aerospace, automobile and medical equipment. Subsidiaries include Shanghai Intech Electro Mechanical Products Co. Ltd., Shanghai Intech Electronics Manufacturing Co. Ltd. and Shanghai Intech Precision Mechanical Products Manufacturing Co. Ltd., located in Shanghai, China. Worldwide sells its advanced solar modules under the AmeriSolar brand name in more than ten countries including the United Kingdom, Germany, Italy, Switzerland, Portugal, France, Spain, Australia, South Korea, and the United States.
Forward-looking statements:
The above news release contains forward-looking statements. The statements contained in this document that are not statements of historical fact, including but not limited to, statements identified by the use of terms such as "anticipate," "appear," "believe," "could," "estimate," "expect," "hope," "indicate," "intend," "likely," "may," "might," "plan," "potential," "project," "seek," "should," "will," "would," and other variations or negative expressions of these terms, including statements related to expected market trends and the Company's performance, are all "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of external factors, uncertainties, business risks, and other risks identified in filings made by the company with the Securities and Exchange Commission. Actual results may differ materially from those indicated by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
Contact:
At the company:
Worldwide Energy and Manufacturing USA, Inc.
Jimmy Wang
650-794-9888, Ext. 221
Investor relations:
Dave Gentry
RedChip Companies, Inc.
1-800-733-2447, Ext. 104
TheGreenBaron.com • EvergreenMarketingInc.com • Disclaimer • Remove Me
PLEASE NOTE: To ensure delivery to your inbox (not bulk or junk folders), please add thegreenbaron@att.net to your address book.